Laronde Revenue and Competitors

Boston, MA USA

Location

$490M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Laronde's estimated annual revenue is currently $27M per year.(i)
  • Laronde's estimated revenue per employee is $155,000
  • Laronde's total funding is $490M.

Employee Data

  • Laronde has 174 Employees.(i)
  • Laronde grew their employee count by -21% last year.

Laronde's People

NameTitleEmail/Phone
1
CTOReveal Email/Phone
2
CEO and President CEO Partner, Flagship PioneeringReveal Email/Phone
3
Head ImmunologyReveal Email/Phone
4
Head Data ScienceReveal Email/Phone
5
Head FinanceReveal Email/Phone
6
VP, Head Intellectual Property and ContractsReveal Email/Phone
7
SVP Infectious Disease and VaccinesReveal Email/Phone
8
Head In Vivo PharmacologyReveal Email/Phone
9
VP, Head Technical OperationsReveal Email/Phone
10
Head ImmunologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Laronde?

keywords:N/A

$490M

Total Funding

174

Number of Employees

$27M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Laronde News

2022-04-13 - Biotech venture capital: Top 10 money-raisers of 2021

Laronde hopes to develop 100 new mRNA-based medicines over the next 10 years. (No, that's not a typo.) (flagship pioneering).

2022-04-13 - Catherine Spaak, Leading Lady of Italian Films, Dies at 77

She starred in features including 'Il Sorpasso,' 'La Ronde,' 'The Cat o' Nine Tails,' 'Weekend at Dunkirk' and 'Diary of a Telephone Operator.'.

2022-03-30 - Exmouth A La Ronde travelling trunks return

National Trust A La Ronde Devon - Three historically important travelling trunks which are believed to date from before 1796 have recently...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.1M176-26%$367M
#2
$52.6M177N/AN/A
#3
$28.2M1775%N/A
#4
$32.1M17712%N/A
#5
$34.5M17829%$338M